Free Republic

Canadian Dr. Charles Hoffe has administered 900 doses of the Moderna mRNA vaccine. After a number of these patients complained of persistent fatigue he decided to test for blood clots. He found that 62% of these vaccinated patients had microscopic blood clots. While these clots are not large enough to cause a immediate health danger, he is concerned that from a longer term perspective the vaccines might pose a serious risk. He speculates that "the vaccines stimulate the body to produce billions of spike proteins. The hope is that these will cue the body's immune system to develop antibodies to...

Laboratory studies indicate that a cheap generic drug reduces SARS-CoV-2 infection in human cells by up to 70%. The drug, called fenofibrate, regulates cholesterol levels but also destabilizes the spike protein on SARS-CoV-2 and inhibits binding to human cells. It was effective against all the SARS-CoV-2 variants that the scientists tested in vitro. An international effort — involving scientists from Keele University and the University of Birmingham, both in the United Kingdom, and the San Raffaele Scientific Institute in Milan — has found that a drug that people formerly used to control cholesterol levels could be an effective treatment against...

Israeli scientists and researchers are racing to find a cure for COVID-19, as global consensus is forming among medical professionals that vaccination is not going to eliminate corona. When Israel launched its mass vaccination campaign, there were many who believed there would no longer be a need for medication, Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, told The Jerusalem Post. “Now we know that this was an illusion,” he said. “Even in Israel, not everyone is taking the vaccine. There is quite a big population of youngsters...

Doctors and researchers around the world found success using the following four treatments. Hear the background on these treatments from their own mouths. See List & Watch Videos....

A study conducted by professor Yaakov Nahmias at Hebrew University in Israel has found that an existing cholesterol drug, fenofibrate, could ‘downgrade’ Covid-19 threat level to that of a common cold. The findings allegedly come from lab tests on human lung tissue infected with SARS-CoV-2, the virus that causes Covid-19 . . .

Could a simple drug that has been on the market for decades be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)'s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week's Cell Press Sneak Peak. Over the last three months, Nahmias and Dr. Benjamin tenOever at New York's Icahn School of Medicine at Mount Sinai have focused on the ways in which the SARS-CoV-2 changes patients' lungs in order to reproduce itself. Their major finding? This virus prevents the routine burning of carbohydrates. As a result, large amounts of...

Could a simple drug, that has been on the market for decades, be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)’s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week’s Cell Press’ Sneak Peak. Over the last three-months, Nahmias and Dr. Benjamin tenOever at New York’s Mount Sinai Medical Center have focused on the ways in which the SARS-CoV-2 (AKA the coronavirus that’s causing our current pandemic) changes patients’ lungs in order to reproduce itself. Their major finding? This virus prevents the routine burning of carbohydrates. As a...